Tradjenta

Linagliptin · Boehringer Ingelheim; Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

44 regulatory and trial events tracked for Tradjenta, covering 2011-05-02 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Metformin, Empagliflozin With Sitagliptin vs Linagliptin in Type 2 Diabetes [Phase 4]